文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

引导性提示改善尿路感染抗生素选择:INSPIRE随机临床试验

Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.
PubMed 文献 · JAMA · 2024-01-01
一句话结论对非危重尿路感染住院成人,CPOE风险提示联合反馈与教育可安全减少经验性广谱抗生素使用。

INSPIRE集群随机试验纳入59家美国社区医院、127403例非危重尿路感染住院成人,比较CPOE管理套餐(教育、反馈及基于风险的实时提示)与常规管理对住院前3天经验性抗生素选择的影响。干预组经验性广谱抗生素治疗天数较常规组降低17.4%(95%CI 11.2%-23.2%),率比0.83(95%CI 0.77-0.89),P<.001。至ICU转出平均天数(6.6 vs 7.0天)和住院时长(6.3 vs 6.5天)两组无显著差异。提示该策略可在不延长住院或增加ICU转出的情况下减少广谱抗生素过度使用。

要点

  • CPOE提示针对低MDRO风险(估计绝对风险<10%)且被开具广谱抗生素的尿路感染患者,推荐经验性标准谱抗生素。
  • 干预组经验性广谱抗生素治疗天数降低17.4%(95%CI 11.2%-23.2%),率比0.83(95%CI 0.77-0.89),P<.001。
  • 至ICU转出平均天数常规组6.6天 vs 干预组7.0天,住院时长常规组6.3天 vs 干预组6.5天,均无显著差异。
  • 研究人群为≥18岁非危重尿路感染住院成人,中位Elixhauser合并症指数4(IQR 2-5)。

适用人群与场景

  • ≥18岁因尿路感染住院的非危重成人,来自59家美国社区医院。
  • 基线期2017年4月1日至2018年9月30日共18个月,干预期2019年4月1日至2020年6月30日共15个月。

诊断标准与关键阈值

  • MDRO尿路感染估计绝对风险<10%的患者被CPOE提示推荐经验性标准谱抗生素。

处置流程与药物剂量

  • CPOE管理套餐包括教育、反馈及实时、基于风险的CPOE提示,在患者被开具广谱抗生素时推荐经验性标准谱抗生素(针对低MDRO风险者)。

研究设计与关键结果

  • 集群随机试验,59家美国社区医院(干预29家,常规30家),127403例尿路感染住院成人(基线期71991例,干预期55412例),平均年龄69.4(17.9)岁,30.5%男性,中位Elixhauser合并症指数4(IQR 2-5)。
  • 主要终点:经验性(住院前3天)广谱抗生素治疗天数,干预组较常规组降低17.4%(95%CI 11.2%-23.2%),率比0.83(95%CI 0.77-0.89),P<.001。
  • 安全终点:至ICU转出平均天数常规组6.6天 vs 干预组7.0天;住院时长常规组6.3天 vs 干预组6.5天,均无显著差异。

证据类型、等级与局限

  • 证据类型:集群随机临床试验(INSPIRE),注册号NCT03697096。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对非危重尿路感染住院成人,CPOE实时风险提示联合反馈与教育可减少经验性广谱抗生素使用,且未改变住院时长或至ICU转出天数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Urinary tract infection (UTI) is the second most common infection leading to hospitalization and is often associated with gram-negative multidrug-resistant organisms (MDROs). Clinicians overuse extended-spectrum antibiotics although most patients are at low risk for MDRO infection. Safe strategies to limit overuse of empiric antibiotics are needed.

OBJECTIVE: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO risk estimates could reduce use of empiric extended-spectrum antibiotics for treatment of UTI.

DESIGN, SETTING, AND PARTICIPANTS: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time and risk-based CPOE prompts; 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults (≥18 years) hospitalized with UTI with an 18-month baseline (April 1, 2017-September 30, 2018) and 15-month intervention period (April 1, 2019-June 30, 2020).

INTERVENTIONS: CPOE prompts recommending empiric standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics who have low estimated absolute risk (<10%) of MDRO UTI, coupled with feedback and education.

MAIN OUTCOMES AND MEASURES: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy. Safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes were assessed using generalized linear mixed-effect models to assess differences between the baseline and intervention periods.

RESULTS: Among 127 403 adult patients (71 991 baseline and 55 412 intervention period) admitted with UTI in 59 hospitals, the mean (SD) age was 69.4 (17.9) years, 30.5% were male, and the median Elixhauser Comorbidity Index count was 4 (IQR, 2-5). Compared with routine stewardship, the group using CPOE prompts had a 17.4% (95% CI, 11.2%-23.2%) reduction in empiric extended-spectrum days of therapy (rate ratio, 0.83 [95% CI, 0.77-0.89]; P < .001). The safety outcomes of mean days to ICU transfer (6.6 vs 7.0 days) and hospital length of stay (6.3 vs 6.5 days) did not differ significantly between the routine and intervention groups, respectively.

CONCLUSIONS AND RELEVANCE: Compared with routine stewardship, CPOE prompts providing real-time recommendations for standard-spectrum antibiotics for patients with low MDRO risk coupled with feedback and education significantly reduced empiric extended-spectrum antibiotic use among noncritically ill adults admitted with UTI without changing hospital length of stay or days to ICU transfers.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03697096.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Gohil SK, Septimus E, Kleinman K, et al. Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial. JAMA. 2024. PMID: 38639723. doi:10.1001/jama.2024.6259

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。